Dr Yeo Siaw Ing

Dr Yeo Siaw Ing is a Senior Consultant in the Department of Rheumatology and Immunology, Singapore General Hospital (SGH). She graduated from the University of London in 1993 and completed her specialist training in Rheumatology and General Internal Medicine with the London Deanery in 2004. She was appointed Consultant Rheumatologist at Barnet and Chase Farm Hospitals NHS Trust, North London, subsequently.

In 2006, Dr Yeo was appointed Honorary Clinical Associate, Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Hong Kong. Her work at the University of Hong Kong included clinical duties, co-investigator in multiple clinical trials involving novel therapies for rheumatoid arthritis and systemic lupus erythematosus, and, teaching of undergraduate and postgraduate students.

Dr Yeo joined SGH in 2013 and is currently the Department’s Director of Clinical Services. As the Director of Clinical Services, she endeavours to optimise delivery of care and the range of services available for Rheumatology patients at the Autoimmunity and Rheumatology Centre (ARC) and Immunology Hub. She is also the Lead for the Singapore National Biological Disease-Modifying Anti-Rheumatic Drug Registry.

• Fellow of the Royal College of Physicians (FRCP) London, 2020
• Singapore Management University, SingHealth Graduate Diploma in Healthcare 2016
• FAMS (Rheumatology), Academy of Medicine Singapore, 2015
• Academic Excellence Award, Diploma in Clinical Acupuncture, University of Hong Kong, 2008
• MSc (Rheumatology), University of London, United Kingdom, 2001
• Member of the Royal College of Physicians (MRCP) London, 1996
• MBBS, University of London, United Kingdom, 1993

• Senior Consultant, Department of Rheumatology and Immunology, Singapore General Hospital (SGH)

• Director, Clinical Services, Department of Rheumatology and Immunology, Singapore General Hospital (SGH)

• Chairman, Pharmacy and Therapeutics Committee, Singapore General Hospital (SGH)

• SingHealth Pharmacy and Therapeutics Council - Member

• National Pharmacy and Therapeutics Committee - Member

• Adjunct Assistant Professor, Duke-NUS Medical School, Singapore

• Clinical Senior Lecturer, Yong Loo Lin School of Medicine, National University of Singapore

• Clinical Teacher, Lee Kong Chia School of Medicine

• Rheumatology Senior Residency Program – Core Faculty

• Creation of a National Biologics Registry for Rheumatology (in collaboration with Chapter of Rheumatologists, Singapore) – Lead

• Singapore Productivity Association Gold Award 2019

• Division of Medicine Best QI Project Team Award 2018

• Quality Improvement Project Award for RISE Award 2018

• Singapore Health Quality Service Award: Star Award 2016, Silver Award 2015 & 2018

• RISE (Residency In SingHealth Excels award), Outstanding Faculty Award 2014

• Singapore General Hospital, Service Quality Award, Service with a Heart Award 2014

• Rheumatoid arthritis
• Novel therapies
• Biologics registry

1. Kwan YH, Fong W, Ang XL, Tan CS, Tai BC, Huang Y, Bilger M, Phang JK, Tan HC, Lee JV, Sun L, Tan CT, Dong BQ, Koh HL, Leung YY, Lui NL, Yeo SI, Ng SC, Fong KY, Thumboo J, Ostbye T. Traditional Chinese Medicine (TCM) colloborative model of care for patients with axial spondyloarthritis (AcuSpA): Protocol for a randomized controlled trial. 2018. Trials, 20. 46 (2019)

2. YC Lim, WG Teo, MN Eng, HM Cheen, XY Tay, SI Yeo, TG Lim. Adherence to Biologic Disease Modifying Antirheumatic Drugs in Patients with Inflammatory Arthritis. EULAR 2018 (Abstract)

3. Law Annie HN, Yeo SI. Erdheim-Chester Disease: A case of cardiac and hypopyseal involvement showing positive response with high dose pegylated interferon-A. J Rheum Dis Treat. 2016, 2:031; Vol.2 Issue 1. ISSN 2469-5726.

4. Yeo SI, Wong RWS, Trendell-Smith NJ. Multiple bullae and pulmonary nodular amyloidosis: A rare complication of Primary Sjogren’s Syndrome. Proceedings of Singapore Healthcare. 2014 Nov; 23 (4): 316-319

5. Yeo SI. HLA B*5801: utility and cost-effectiveness in the Asia-Pacific Region. Int J Rheum Dis. 2013 Jun; 16 (3):254-7.

6. S Davies R, Lomer M, Yeo S, Avloniti K, Sangle S, D’Cruz D. Lupus 2012. May;21(6): 649-55. Weight loss and improvements in fatigue in systemic lupus erythematosus: a controlled trial of a low glycaemic index diet versus a calorie restricted diet in patients treated with corticosteroids.

7. Yeo SI, Davies RJ, Avloniti K, Lomer M, Sangle S, Hughes GRV, D’Cruz DP. The low glycaemic index diet in systemic lupus erythematosus: Feasibility, safety and tolerability.Rheumatology Mar 2005; 44:Abs Suppl 1:358.

8. Davies RJ, Yeo SI, Avloniti K, Lomer M, Sangle S, Hughes GRV, D’Cruz DP. A pilot study of a low glycaemic index diet in systemic lupus erythematosus: weight loss and cardiovascular risk factors. Rheumatology Mar 2005; Abs Suppl 1:359.

9. Yeo SI, Bennett AN, Gibson T. Ocular toxicity and hydroxychloroquine: Audit of current practice. Rheumatology Mar 2004;43: Abs Suppl ii:335

10. Scott DL, Farrow S, Yeo SI. Early developments in combination therapy. Clin Exp Rheumatol. 1999 Nov-Dec; 17(6 Suppl 18): S8-12

11. Yeo SI, Scott DL. Do patients and physicians assess function differently? EULAR 1999; Abs Suppl: 145(594)

12. Yeo SI, Pitt PI. Why bother to close the loop? Audit of rheumatological therapy in the perioperative period. EULAR 1999; Abs Suppl:22(46)

13. Greenwood M, Scott DL, Carr AJ, Deodhar A, Dolan L, Doyle DV, Houssein DA, Rojkovich B, Woolf AD, Yeo SI. Pain and disability in rheumatoid arthritis. EULAR 1999; Abs Suppl: 91(347)